These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20664291)

  • 1. Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005.
    Christensen KL; Holman RC; Hammett TA; Belay ED; Schonberger LB
    Neuroepidemiology; 2010; 35(3):178-84. PubMed ID: 20664291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data.
    Holman RC; Janssen RS; Buehler JW; Zelasky MT; Hooper WC
    Neurology; 1991 Nov; 41(11):1733-6. PubMed ID: 1944901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection.
    Holman RC; Török TJ; Belay ED; Janssen RS; Schonberger LB
    Neuroepidemiology; 1998; 17(6):303-9. PubMed ID: 9778596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
    Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
    J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
    Antinori A; Cingolani A; Lorenzini P; Giancola ML; Uccella I; Bossolasco S; Grisetti S; Moretti F; Vigo B; Bongiovanni M; Del Grosso B; Arcidiacono MI; Fibbia GC; Mena M; Finazzi MG; Guaraldi G; Ammassari A; d'Arminio Monforte A; Cinque P; De Luca A;
    J Neurovirol; 2003; 9 Suppl 1():47-53. PubMed ID: 12709872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
    Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
    J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
    Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
    An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
    Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
    Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
    Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era.
    Casado JL; Corral I; García J; Martinez-San Millán J; Navas E; Moreno A; Moreno S
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):179-87. PubMed ID: 23948752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population.
    Eng PM; Turnbull BR; Cook SF; Davidson JE; Kurth T; Seeger JD
    Neurology; 2006 Sep; 67(5):884-6. PubMed ID: 16966559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
    Cinque P; Pierotti C; Viganò MG; Bestetti A; Fausti C; Bertelli D; Lazzarin A
    J Neurovirol; 2001 Aug; 7(4):358-63. PubMed ID: 11517417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy.
    Kraemer C; Evers S; Nolting T; Arendt G; Husstedt IW
    J Neurol; 2008 Apr; 255(4):526-31. PubMed ID: 18202814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
    Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
    Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.